Showing 10,101 - 10,120 results of 35,226 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (nn decrease)) ))', query time: 0.99s Refine Results
  1. 10101

    The synthetic lethality of the <i>erd1</i>Δ mutation with the Neo1p-depleted <i>cfs1</i>Δ mutation is not caused by reduced levels of cytoplasmic Pi. by Mamoru Miyasaka (9187916)

    Published 2020
    “…Cells were grown and spotted, as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0236520#pone.0236520.g001" target="_blank">Fig 1B</a>, in YPGA (galactose) or YPDA (glucose) medium with either 20 mM Pi or 50 mM Pi and then incubated at 30°C for 1.5 d. …”
  2. 10102

    Rab11a is essential for the replication of multiple IAV strains. by Julianna Han (9354280)

    Published 2021
    “…Control A549 and Rab11a KO cells were infected with H5N1 (MOI = 1), and H3N2 (MOI = 5), and viral titers were measured at 24 hpi by plaque assay. …”
  3. 10103

    Novel Allosteric Inhibitors of Deoxyhypusine Synthase against Malignant Melanoma: Design, Synthesis, and Biological Evaluation by Kai-li Liu (11378101)

    Published 2021
    “…Furthermore, by western blot analysis, compound <b>8m</b> effectively activated caspase 3 and decreased the expressions of GP-100, tyrosinase, eIF5A2, MMP2, and MMP9. …”
  4. 10104

    Novel Allosteric Inhibitors of Deoxyhypusine Synthase against Malignant Melanoma: Design, Synthesis, and Biological Evaluation by Kai-li Liu (11378101)

    Published 2021
    “…Furthermore, by western blot analysis, compound <b>8m</b> effectively activated caspase 3 and decreased the expressions of GP-100, tyrosinase, eIF5A2, MMP2, and MMP9. …”
  5. 10105

    Novel Allosteric Inhibitors of Deoxyhypusine Synthase against Malignant Melanoma: Design, Synthesis, and Biological Evaluation by Kai-li Liu (11378101)

    Published 2021
    “…Furthermore, by western blot analysis, compound <b>8m</b> effectively activated caspase 3 and decreased the expressions of GP-100, tyrosinase, eIF5A2, MMP2, and MMP9. …”
  6. 10106

    Novel Allosteric Inhibitors of Deoxyhypusine Synthase against Malignant Melanoma: Design, Synthesis, and Biological Evaluation by Kai-li Liu (11378101)

    Published 2021
    “…Furthermore, by western blot analysis, compound <b>8m</b> effectively activated caspase 3 and decreased the expressions of GP-100, tyrosinase, eIF5A2, MMP2, and MMP9. …”
  7. 10107

    Management of Recurrent Bronchopleural Fistula: A Multidisciplinary Approach for A Reconstructive Challenge by Karishma Chandarana (4607131)

    Published 2022
    “…<p> </p> <p>Urgent pneumonectomy for benign disease is rare but highly morbid, with a perioperative mortality approaching 50 percent. …”
  8. 10108

    Temporal and spatial variation of potassium balance in agricultural land at national and regional levels in China by Yingxia Liu (792213)

    Published 2017
    “…<div><p>Linking potassium (K) balance to soil fertility creates a valuable indicator for sustainability assessment in agricultural land-use systems. …”
  9. 10109

    Reduced <i>Fgf8</i> expression in <i>Six1</i><sup><i>Cko/Cko</i></sup> mutant (<i>Eya1</i><sup><i>CreER</i></sup><i>;Six1</i><sup><i>fl/fl</i></sup> given tamoxifen from E11.5–12.5... by Ting Zhang (102583)

    Published 2017
    “…<p>(A) Immunostaining for S100A (red) on sections of cochleae from E18.5 wild-type or <i>Six1</i><sup><i>Cko/Cko</i></sup> littermate embryos. …”
  10. 10110

    Table 1_Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine.docx by Zhifei Chen (1740625)

    Published 2025
    “…Our study endeavored to compare the dynamics of neutralizing antibodies generated by four distinct booster vaccines against three kinds of live SARS-CoV-2 virus (wild-type, Delta AY.23, and Omicron BA5.2). …”
  11. 10111

    Hemodynamic parameters. by Paulina Kania-Olejnik (19797617)

    Published 2024
    “…Anteroposterior diameter increased from 36.5±5.0mm to 38.4±5.5mm (<i>p</i> = 0.05). TA contraction decreased from 7±2% in SR to 2±1% in AF (p = 0.001). …”
  12. 10112

    Tricuspid annular dimensions. by Paulina Kania-Olejnik (19797617)

    Published 2024
    “…Anteroposterior diameter increased from 36.5±5.0mm to 38.4±5.5mm (<i>p</i> = 0.05). TA contraction decreased from 7±2% in SR to 2±1% in AF (p = 0.001). …”
  13. 10113

    Regional tricuspid annular perimeter. by Paulina Kania-Olejnik (19797617)

    Published 2024
    “…Anteroposterior diameter increased from 36.5±5.0mm to 38.4±5.5mm (<i>p</i> = 0.05). TA contraction decreased from 7±2% in SR to 2±1% in AF (p = 0.001). …”
  14. 10114
  15. 10115

    Disrupting Glycolysis-promoting Genes Extends <i>C</i>. <i>elegans</i> Healthspan, Whereas High Glucose and Gluconeogenic Gene Disruptions Shorten Healthspan. by Brian Onken (86790)

    Published 2020
    “…On day 15, <i>fbp-1(RNAi)</i> decreases swimming rates by 44%, and <i>pck-2(RNAi)</i> animals moved too slowly to measure (or were dead) (marked as N/A). …”
  16. 10116

    TcdA-induced Rac1 glucosylation and cytotoxicity are dynamin-dependent. by Ramyavardhanee Chandrasekaran (3394916)

    Published 2016
    “…RT-PCR confirms that siRNA treatment resulted in a decrease in Dyn-1 mRNA expression. <b>(B) Pharmacological inhibition of dynamin GTPases prevents Rac1 modification by TcdA</b>. …”
  17. 10117
  18. 10118
  19. 10119
  20. 10120